Hospital costs in patients with nosocomial methicillin-resistant or methicillin-susceptible staphylococcus aureus bloodstream infection

Infection Control and Hospital Epidemiology

Volumn 30, Issue 11, 2009, Pages 1127-

  Vandijck, Dominique M ^a,b,d   Annemans, Lieven ^a   Vogelaers, Dirk P ^b,c   Blot, Stijn I ^b,c  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY COLLEGE GHENT   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; METICILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BLOODSTREAM INFECTION; HEALTH CARE UTILIZATION; HOSPITAL COST; HOSPITAL INFECTION; HUMAN; LENGTH OF STAY; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; STATISTICAL MODEL; TREATMENT DURATION; BACTEREMIA; CROSS INFECTION; DRUG EFFECT; ECONOMICS; MICROBIOLOGY; NOTE; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CROSS INFECTION; HOSPITAL COSTS; HUMANS; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 71949123786     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/647984     Document Type: Letter

References (9)

1. Vandijck DM, Blot SI, Decruyenaere JM, et al. Costs and length of stay associated with antimicrobial resistance in acute kidney injury patients with bloodstream infection. Acta Clin Belg 2008; 63:31-38.
2. Vandijck DM, DepaemelaereM, Labeau SO, et al. Daily cost of antimicrobial therapy in patients with intensive care unit-acquired, laboratory-confirmed bloodstream infection. Int J Antimicrob Agents 2008; 31:161-165.
3. Ben-David D, Novikov I, Mermel LA. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection? Infect Control Hosp Epidemiol 2009; 30:453-460.
4. Depuydt PO, Vandijck DM, Bekaert MA, et al. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated- pneumonia. Crit Care 2008; 12:R142. http://ccforum.com/content/12/6/R142. Published November 17, 2008. Accessed November 17, 2008.
5. Vandijck DM, Blot SI, Labeau SO, et al. Candidemia in critically ill patients: an analysis of daily antifungal therapy related costs. J Mycol Med 2008; 18:96-99.
6. Shurland SM, Stine OC, Venezia RA, et al. Colonization sites of USA300 methicillin-resistant Staphylococcus aureus in residents of extended care facilities. Infect Control Hosp Epidemiol 2009; 30:313-318.
7. Hoste EA, Vandijck DM, Van Holder RC, et al. Health implications of antimicrobial resistance for patients with acute kidney injury and bloodstream infection. Infect Control Hosp Epidemiol 2007; 28:1107-1110.
8. Iosifidis E, Antachopoulos C, Tsivitanidou M, et al. Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece. Infect Control Hosp Epidemiol 2008; 29:615-622.
9. Blot S, Depuydt P, Vandewoude K, De Bacquer D. Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis 2007; 20:391-396.